Cargando…
Engineering tumor-specific catalytic nanosystem for NIR-II photothermal-augmented and synergistic starvation/chemodynamic nanotherapy
BACKGROUND: As an emerging therapeutic modality, chemodynamic therapy (CDT), converting hydrogen peroxide (H(2)O(2)) into highly toxic reactive oxygen species (ROS), has been developed for tumor-specific therapy. However, the deficiency of endogenous H(2)O(2) and high concentration of glutathione (G...
Autores principales: | Zhou, Shuixiu, Xu, Jiahuan, Dai, Yanfei, Wei, Yan, Chen, Liang, Feng, Wei, Chen, Yu, Ni, Xuejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701438/ https://www.ncbi.nlm.nih.gov/pubmed/36435848 http://dx.doi.org/10.1186/s40824-022-00317-y |
Ejemplares similares
-
Highly Efficient 2D NIR‐II Photothermal Agent with Fenton Catalytic Activity for Cancer Synergistic Photothermal–Chemodynamic Therapy
por: Zhang, Qiuhong, et al.
Publicado: (2020) -
NIR-II responsive PEGylated nickel nanoclusters for photothermal enhanced chemodynamic synergistic oncotherapy
por: Qian, Yong, et al.
Publicado: (2022) -
Extracellular matrix-degrading STING nanoagonists for mild NIR-II photothermal-augmented chemodynamic-immunotherapy
por: Zhan, Meixiao, et al.
Publicado: (2022) -
Copperphosphotungstate Doped Polyanilines Nanorods for GSH-Depletion Enhanced Chemodynamic/NIR-II Photothermal Synergistic Therapy
por: Ye, Sheng, et al.
Publicado: (2023) -
Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers
por: Liu, Yang, et al.
Publicado: (2017)